S. Manuel Martinez García
President and CEO
Sedecal S.A.
C/Pelaya, 9-13 Pol Industrial Rio De Janeiro
28110 ALGETE Madrid
Spain
mmartinez@sedecal.com
mmartinezjr@sedecal.comFEI 3002495042Issued May 5, 2025Center for Devices and Radiological Health
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3002495042.
Violations5
Issue DateMay 5, 2025
Product TypeMedical Devices
StatusOpen
Letter Details
Firm
Sedecal S.A.
Location
S. Manuel Martinez García
President and CEO
Sedecal S.A.
C/Pelaya, 9-13 Pol Industrial Rio De Janeiro
28110 ALGETE Madrid
Spain
mmartinez@sedecal.com
mmartinezjr@sedecal.com
FEI Number
3002495042
Country
Spain
Issue Date
May 05, 2025
Issuing Office
Center for Devices and Radiological Health
Product Type
Medical Devices
Status
Open
Summary
Sedecal S.A., a Spanish manufacturer of diagnostic X-ray devices (DX-D 100, DX-D 600, and MobileDiagnost wDR systems), failed to comply with current good manufacturing practice requirements under the Quality System regulation. The company inadequately established and maintained corrective and preventative action (CAPA) procedures, specifically failing to document a proper risk assessment for mobile X-ray units that were reported to self-propel and crash into control panels or nearly strike patients. This manufacturing deficiency rendered the devices adulterated under federal law, with the violations identified during an FDA inspection conducted January 20-24, 2025.